Efficiency

CureVac COVID-19 vaccine protects mice against emerging SARS-CoV-2 mutations

ChAdOx1 nCoV-19 vaccine does not protect against South African SARS-CoV-2 variant

A new study provides a comparative analysis of a dozen COVID-19 vaccines

A study comparing antibiotic-only versus surgical treatment for uncomplicated acute appendicitis

Nanobody works against all variants of SARS-CoV-2 stress in an animal model

Researchers are piloting a new drug development pathway for the treatment of multiple sclerosis, asthma

There are benefits to delaying second doses of COVID-19 vaccines, but long-term outcomes depend on strong immunity

Complications may be exacerbated by SARS-CoV-2 changes along the way

Self-assembled candidate nanoparticles are an effective vaccine for SARS-CoV-2

A single dose of the SARS-CoV-2 vaccine candidate stimulates a neutralization response in COVID-19 convalescents